TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Madrigal Pharmaceuticals
Madrigal Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences

Madrigal Pharmaceuticals will participate in three upcoming healthcare investor conferences in November and December 2025, presenting live webcasts about their MASH treatment Rezdiffra.

Insights
MDGL   positive

Company is actively presenting at multiple investor conferences, showcasing ongoing research and development of Rezdiffra for MASH treatment, indicating growth and investor engagement